SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The ticket is $Testicle. EVERY SINGLE ONE OF YOU CAME FROM A $Testicle. $Testicle always bounce.   We have a website on which you can create art or memes. We have a community. We have a raid group. We aim to provide the best testicular care on CT.   We might even have to call on our nefarious leader, Harry Bolz. Alright Chad, SACK TF. Or else you’re a Low T beta male.   If you have questions and or concerns please feel to reach out to a team member on how you can acquire or become a high testosterone male in a sea of betas. I mean how else does one live if not as a High T male?

Testicle

TESTICLE CRYPTO is trending, generating significant community buzz and disbelief due to its provocative name and unexpected popularity. This token has become a focal point for intense debate, with many viewing it as indicative of a speculative and potentially "broken" altcoin market, while others engage with it in jest or with genuine curiosity about its momentum.

Ballsackcoin

Ballsackcoin (BALLSACK CRYPTO) is trending, with active community discussions highlighting its recent surge in attention. The primary focus of conversation revolves around whether the project is still actively functioning and viable, fueling curiosity among market participants.

The Kraft Heinz Co. engages in the manufacture and market of food and beverage products. It operates through the North America and International geographical segments. The company was founded on July 2, 2015, and is headquartered in Pittsburgh, PA.

Kraft Heinz Co

Kraft Heinz is a key talking point as investors eye a planned company separation into two independent entities and the recent appointment of a new CEO, generating buzz around potential value creation. Despite recent analyst downgrades perceived by many as market manipulation, the community is actively discussing KHC as a deeply undervalued consumer staples play, highlighting its attractive dividend and defensive characteristics amidst broader market shifts.

Constellation Energy Corp. engages in the generation, supply, and marketing of clean electricity, and renewable energy products and solutions. The firm also offers wholesale energy, retail products and services. It operates under the following geographical segments: Mid-Atlantic, Midwest, New York, Electric Reliability Council of Texas (ERCOT), and Other Power Regions Segment. The company was founded in 1960 and is headquartered in Baltimore, MD.

Constellation Energy Corporation

Constellation Energy Corp

Constellation Energy is trending amid a significant debate surrounding proposed plans for tech giants to fund new power generation for surging AI data center demand in the PJM region, which initially triggered a market pullback. Despite concerns over potential electricity price caps and their impact on existing generators, community sentiment highlights a belief in a long-term 'AI needs power' narrative, reinforced by recent record-clearing PJM capacity auction prices and a federal loan to restart the Three Mile Island reactor. This broader context positions CEG at the forefront of powering the evolving energy landscape for advanced technology.

Caterpillar, Inc. engages in the business of manufacturing construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives. It operates through the following segments: Construction Industries, Resource Industries, Energy and Transportation, Financial Products, and All Other. The Construction Industries segment is involved in supporting customers using machinery in infrastructure and building construction applications. The Resource Industries segment offers machinery in mining, heavy construction, quarry, and aggregates. The Energy and Transportation segment focuses on reciprocating engines, turbines, diesel-electric locomotives, and related services across industries serving oil and gas, power generation, industrial, and transportation applications including marine- and rail-related businesses. The Financial Products segment provides financing alternatives to customers and dealers for Caterpillar products and services, as well as financing for power generation facilities. The All Other segment includes activities such as the business strategy, product management and development, manufacturing, and sourcing of wear and maintenance components products, parts distribution, integrated logistics solutions, distribution services responsible for dealer development, and administration. The company was founded on April 15, 1925 and is headquartered in Irving, TX.

Caterpillar Inc.

Caterpillar is trending due to significant attention on its pivotal role in the AI infrastructure buildout, with surging demand for its power generation solutions for data centers driving conversation. This unexpected growth driver has led to notable analyst upgrades and strong bullish sentiment among investors, even as some question the sustainability of its rapid rally and current valuation.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors digest a reported drop in New York's online sports betting revenue during the NFL Wild Card weekend and increasing regulatory pressure from the NCAA regarding college sports wagering. The community is actively debating whether emerging prediction markets are intensifying competition or if recent declines are merely short-term volatility, with some viewing the pullback as a buying opportunity ahead of anticipated strong earnings and major sporting events.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Emergent Biosolutions is a major talking point following news that the New York Attorney General is suing its former CEO for insider trading, stemming from past events. While this initially impacted shares, the community is emphasizing that the company itself previously settled the issue and views the subsequent market reaction as an overcorrection. Many investors are actively debating these dynamics, anticipating further upside driven by recent positive developments, including a substantial debt prepayment and new regulatory approvals.

Berachain

Berachain (BERA) is a hot topic following a series of significant ecosystem upgrades, including its Bectra programmable wallet launch and new Proof-of-Liquidity (PoL) vaults, alongside a major liquidity rollover event. The community is actively discussing BERA's unique tri-token system and impressive Total Value Locked (TVL) growth, signaling optimism for its position as a rapidly evolving layer-1 in the DeFi sector.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is trending with strong momentum fueled by increasing institutional adoption, including new ETF filings and significant stablecoin market cap growth. The community actively discusses 'buying the dip' and its expanding ecosystem, positioning Solana as a leading blockchain for economic activity and future growth.

Vanguard Group, Inc. - Vanguard Total Bond Market ETF

Vanguard Total Bond Market ETF

Investors are actively discussing Vanguard Total Bond Market ETF ($BND) amid strong expectations for future Fed rate cuts and a potential economic slowdown. Many in the community view it as a key defensive play and a promising alternative to equities, with members accumulating positions to capitalize on anticipated bond price increases and competitive yields. The prevailing sentiment highlights bonds as a strategic holding for stability and returns as market participants navigate potential volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Scienture has commenced selling Arbli, the first FDA-approved ready-to-use liquid losartan formulation.</li><li>The U.S. losartan market is worth about $256 million annually, offering strong growth potential for Arbli.</li><li>Scienture secured key GPO agreements to expand Arbli’s availability to over 2,500 healthcare facilities nationwide.</li></ul>Scienture Holdings Inc. (SCNX) on Thursday announced the launch of commercial sales for its new product, Arbli (losartan potassium) Oral Suspension, 10 mg/mL.Arbli is the first FDA-approved, ready-to-use oral suspension of losartan potassium, offering patients who require alternatives to pills a safe and consistent treatment option.&nbsp;With the U.S. losartan market generating around $256 million annually and more than 71 million prescriptions written each year, according to IQVIA data, Scienture sees a strong potential for this new product.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Shares of Scienture Holdings surged by more than 122% by Thursday noon. On Stocktwits, retail sentiment around the stock remained in ‘extremely bullish’ territory amid ‘extremely high’ message volume levels.&nbsp;<figure class="image"><img style="aspect-ratio:938/107;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_23_114143_png_e27a7261e9.webp" alt="SCNX’s Sentiment Meter and Message Volume as of 11:25 a.m. ET on Oct. 23, 2025 | Source: Stocktwits" width="938" height="107"><figcaption>SCNX’s Sentiment Meter and Message Volume as of 11:25 a.m. ET on Oct. 23, 2025 | Source: Stocktwits</figcaption></figure>A bullish Stocktwits user said the company’s valuation might reach billions if the product is expanded globally.&nbsp;<stembedurl>https://stocktwits.com/jreddyN/message/633437362</stembedurl><h2 class="st-heading-2">Arbli’s Importance</h2>Arbli is a unique liquid form of losartan, a common medication for high blood pressure. It doesn’t need compounding, offers a smaller dosing volume, and has a long shelf life at room temperature. Arbli is approved to treat hypertension in patients over six years old, to lower stroke risk in those with hypertension and heart enlargement, and manage diabetic kidney disease in certain type 2 diabetes patients.To support Arbli’s market entry, Scienture has secured Pharmacy Benefit Manager-led Group Purchasing Organization (PBM-Led GPO) agreements to broaden commercial coverage and formulary inclusion. Scienture has also finalized contracts with multiple commercial GPOs, allowing Arbli to reach over 2,500 healthcare institutions nationwide.&nbsp;Scienture’s stock has lost over 79% in 2025 and over 82% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/datavault-ai-to-boost-growth-with-new-headquarters-quantum-centers/cLG4mQdR3rQ">Datavault AI To Boost Growth With New Headquarters, Quantum Centers</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Is Scienture Stock Rising Today?

Scienture has commenced selling Arbli, the first FDA-approved ready-to-use liquid losartan formulation.

Equity

Scienture Holdings, Inc. engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Commack, NY.

Current Price	$0.53
Prev Close	$0.5227
Open	$0.509
Dividend Yield	0.00%
50-Day Moving Average	$0.5846
Beta	1.15
Avg. Volume	1.65M
PE Ratio	-0.29

52-Week High	$4.50
52-Week Low	$0.461
Market Capitalization	$21.53M
EPS (Annual)	-$5.49
Price to Book	0.15
Revenue Per Employee	$7,191.74
Enterprise Value/EBITDA	N/A

SCNX
Scienture Holdings Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest SCNX News

SCNXScienture Holdings Inc.